Can artificial intelligence really cut biomanufacturing timelines from years to hours? The answer is yes — and it’s already happening.

In this episode, we sit down with Justin Byers, founder and CEO of Axio BioPharma, to explore how AI-driven biomanufacturing is transforming the development of monoclonal antibodies, biologics, and vaccines. By leveraging machine learning, digital twins, and predictive modeling, Axio is slashing development costs, reducing failure rates, and accelerating drug development pipelines like never before.

Justin shares:

How AI accelerates biomanufacturing from molecule design to full-scale production
Why monoclonal antibodies are the ideal starting point for AI-enabled biologics development
How digital twins of bioreactors and in silico models predict outcomes before wet lab experiments
The role of AI in cell line selection, upstream fermentation, and downstream purification
How predictive AI is reducing failed batches, impurities, and costly manufacturing runs
The regulatory perspective — why the FDA is embracing AI models for drug development
The future of AI in rare disease therapies and personalized medicine
How startups and small biotech companies can now compete with Big Pharma thanks to AI-driven cost savings

Byers explains how Axio’s platform is already saving clients 12–18 months and $1M+ per project, while unlocking opportunities to treat rare and ultra-rare diseases once considered commercially unviable.

If you’re in biopharma, biotech, pharma manufacturing, or drug discovery, this conversation is essential listening.

About the Podcast

AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future.

This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights.

AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.

As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.

This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.

Dr. Andree Bates LinkedIn | Facebook | Twitter

Accelerating Biomanufacturing with AI: Reducing Development Timelines from Years to Hours

AI For Pharma Growth

Accelerating Biomanufacturing with AI: Reducing Development Timelines from Years to Hours